Tous Actualités
Suivre
Abonner Intercell AG

Intercell AG

euro adhoc: Intercell AG
Mergers - Acquisitions - Takeovers
IOMAI shareholders approve acquisition by Intercell

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.
Company Information
01.08.2008
» Iomai shareholders voted in favour of the acquisition at the 
special   shareholder meeting on August 1, 2008 » Important closing 
condition fulfilled - closing expected within the next   few days
Vienna (Austria), August 1, 2008 - Intercell AG today announced that 
the acquisition of Iomai by Intercell has been approved by the 
shareholders of Iomai in a special meeting which was held today at 
Iomai´s offices in Gaithersburg, MD. The merger was approved by 99,97
% of the votes cast - corresponding to more than 71% of the 
outstanding shares entitled to vote at the special meeting. After 
this important condition for the acquisition has been met, the 
closing of the transaction is expected within the next few days.
Transaction Terms
As previously announced, on May 12, 2008, Iomai and Intercell AG 
entered into an Agreement and Plan of Merger (the "Merger Agreement")
whereby Iomai agreed to be acquired by Intercell AG subject to the 
terms and conditions of the Merger Agreement.   Under the terms of 
the Merger Agreement, Intercell will acquire Iomai for USD 6.60 per 
share of Iomai´s common stock representing a fully diluted equity 
value of Iomai of approximately USD 189 million (EUR 122 million).  
Iomai´s public shareholders, representing approximately 59 percent of
Iomai´s outstanding common stock will receive cash. Certain of 
Iomai´s largest shareholders (and their affiliates), together 
representing approximately 41 percent of Iomai´s outstanding common 
stock, agreed to exchange their shares for Intercell stock at an 
exchange ratio corresponding to a value of USD 6.60 per share of 
Iomai common stock upon closing.
end of announcement                               euro adhoc

Further inquiry note:

Intercell AG
Lucia Malfent
Head of Communications
Tel. +43 1 20620-303
lmalfent@intercell.com

Branche: Biotechnology
ISIN: AT0000612601
WKN: A0D8HW
Index: ATX Prime, ATX
Börsen: Wiener Börse AG / official market

Plus de actualités: Intercell AG
Plus de actualités: Intercell AG